Labcorp Holdings Goodwill and Intangible Assets 2010-2025 | LH
- Labcorp Holdings goodwill and intangible assets for the quarter ending June 30, 2025 were $9.908B, a 3.07% increase year-over-year.
- Labcorp Holdings goodwill and intangible assets for 2024 were $9.859B, a 3.94% increase from 2023.
- Labcorp Holdings goodwill and intangible assets for 2023 were $9.485B, a 2.57% increase from 2022.
- Labcorp Holdings goodwill and intangible assets for 2022 were $9.247B, a 20.93% decline from 2021.
Labcorp Holdings Annual Goodwill and Intangible Assets (Millions of US $) |
|
---|---|
2024 | $9,859 |
2023 | $9,485 |
2022 | $9,247 |
2021 | $11,694 |
2020 | $11,713 |
2019 | $11,900 |
2018 | $11,271 |
2017 | $11,567 |
2016 | $9,825 |
2015 | $9,526 |
2014 | $4,575 |
2013 | $4,595 |
2012 | $4,569 |
2011 | $4,303 |
2010 | $4,275 |
2009 | $3,239 |
Labcorp Holdings Quarterly Goodwill and Intangible Assets (Millions of US $) |
|
---|---|
2025-03-31 | $9,908 |
2024-12-31 | $9,859 |
2024-09-30 | $10,023 |
2024-06-30 | $9,552 |
2024-03-31 | $9,613 |
2023-12-31 | $9,485 |
2023-09-30 | $9,608 |
2023-06-30 | $9,336 |
2023-03-31 | $12,028 |
2022-12-31 | $9,247 |
2022-09-30 | $12,025 |
2022-06-30 | $11,979 |
2022-03-31 | $12,138 |
2021-12-31 | $11,694 |
2021-09-30 | $11,662 |
2021-06-30 | $11,498 |
2021-03-31 | $11,555 |
2020-12-31 | $11,713 |
2020-09-30 | $11,534 |
2020-06-30 | $11,300 |
2020-03-31 | $11,294 |
2019-12-31 | $11,900 |
2019-09-30 | $11,837 |
2019-06-30 | $11,860 |
2019-03-31 | $11,271 |
2018-12-31 | $11,271 |
2018-09-30 | $11,354 |
2018-06-30 | $11,473 |
2018-03-31 | $11,913 |
2017-12-31 | $11,567 |
2017-09-30 | $11,740 |
2017-06-30 | $10,263 |
2017-03-31 | $9,971 |
2016-12-31 | $9,825 |
2016-09-30 | $9,846 |
2016-06-30 | $9,576 |
2016-03-31 | $9,663 |
2015-12-31 | $9,526 |
2015-09-30 | $9,630 |
2015-06-30 | $9,781 |
2015-03-31 | $9,886 |
2014-12-31 | $4,575 |
2014-09-30 | $4,556 |
2014-06-30 | $4,615 |
2014-03-31 | $4,606 |
2013-12-31 | $4,595 |
2013-09-30 | $4,592 |
2013-06-30 | $4,593 |
2013-03-31 | $4,539 |
2012-12-31 | $4,569 |
2012-09-30 | $4,550 |
2012-06-30 | $4,283 |
2012-03-31 | $4,297 |
2011-12-31 | $4,303 |
2011-09-30 | $4,234 |
2011-06-30 | $4,320 |
2011-03-31 | $4,290 |
2010-12-31 | $4,275 |
2010-09-30 | $3,417 |
2010-06-30 | $3,372 |
2010-03-31 | $3,293 |
2009-12-31 | $3,239 |
2009-09-30 | $3,197 |
2009-06-30 | $3,011 |
2009-03-31 | $2,976 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $22.177B | $13.009B |
Labcorp Holdings Inc. provides laboratory services which helps doctors, hospitals, pharmaceutical companies, researchers and patients make clear and confident decisions. Labcorp Holdings Inc., formerly known as LABORATORY CP, is based in BURLINGTON, N.C. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Danaher (DHR) | United States | $147.134B | 27.29 |
CVS Health (CVS) | United States | $76.787B | 9.54 |
Elevance Health (ELV) | United States | $65.099B | 8.76 |
Cencora (COR) | United States | $56.278B | 19.58 |
DiDi Global (DIDIY) | China | $25.745B | 27.35 |
Natera (NTRA) | United States | $18.966B | 0.00 |
BioMerieux (BMXMF) | France | $17.681B | 0.00 |
EUROFINS SCIENT (ERFSF) | Luxembourg | $15.851B | 0.00 |
ICON (ICLR) | Ireland | $15.102B | 14.53 |
CochLear (CHEOY) | Australia | $13.402B | 0.00 |
Solventum (SOLV) | United States | $12.933B | 13.69 |
Medpace Holdings (MEDP) | United States | $12.571B | 33.27 |
Revvity (RVTY) | United States | $12.220B | 21.03 |
Viatris (VTRS) | United States | $11.044B | 3.79 |
Avantor (AVTR) | United States | $9.683B | 14.07 |
Sonic Healthcare (SKHHY) | Australia | $9.143B | 0.00 |
Charles River Laboratories (CRL) | United States | $8.690B | 17.03 |
HealthEquity (HQY) | United States | $8.305B | 36.38 |
Caris Life Sciences,�Inc (CAI) | United States | $7.515B | 0.00 |
Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
Bausch + Lomb (BLCO) | Canada | $5.066B | 29.83 |
BrightSpring Health Services (BTSG) | United States | $3.609B | 33.11 |
Sotera Health (SHC) | United States | $3.491B | 19.84 |
Surgery Partners (SGRY) | United States | $2.725B | 35.43 |
Organon (OGN) | United States | $2.654B | 2.82 |
Concentras Parent (CON) | United States | $2.520B | 14.56 |
Alignment Healthcare (ALHC) | United States | $2.327B | 0.00 |
GeneDx Holdings (WGS) | United States | $2.278B | 87.73 |
Progyny (PGNY) | United States | $1.981B | 43.60 |
GoodRx Holdings (GDRX) | United States | $1.786B | 35.71 |
PACS (PACS) | United States | $1.782B | 0.00 |
Premier (PINC) | United States | $1.744B | 13.23 |
Ardent Health (ARDT) | United States | $1.582B | 6.74 |
Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.226B | 0.00 | |
Pediatrix Medical (MD) | United States | $1.080B | 8.22 |
QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
Agilon Health (AGL) | United States | $0.853B | 0.00 |
AMN Healthcare Services Inc (AMN) | United States | $0.758B | 7.10 |
CareDx (CDNA) | United States | $0.712B | 11.12 |
Embecta (EMBC) | United States | $0.686B | 4.62 |
Nutex Health (NUTX) | United States | $0.528B | 7.99 |
InnovAge Holding (INNV) | United States | $0.518B | 0.00 |
Omada Health (OMDA) | $0.495B | 0.00 | |
SBC Medicals (SBC) | United States | $0.493B | 0.00 |
LifeMD (LFMD) | United States | $0.486B | 0.00 |
So-Young (SY) | China | $0.471B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.464B | 10.45 |
Sonida Senior Living (SNDA) | United States | $0.461B | 0.00 |
COMPASS Pathways (CMPS) | United Kingdom | $0.405B | 0.00 |
Enhabit (EHAB) | United States | $0.342B | 28.12 |
Oncology Institute (TOI) | United States | $0.328B | 0.00 |
Performant Healthcare (PHLT) | United States | $0.284B | 0.00 |
Beauty Health (SKIN) | United States | $0.226B | 0.00 |
Pheton Holdings (PTHL) | China | $0.192B | 0.00 |
DocGo (DCGO) | United States | $0.149B | 24.33 |
Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
Ascend Wellness Holdings (AAWH) | United States | $0.090B | 0.00 |
KindlyMD (NAKA) | United States | $0.080B | 0.00 |
Biodesix (BDSX) | United States | $0.065B | 0.00 |
IceCure Medical (ICCM) | Israel | $0.063B | 0.00 |
NeueHealth (NEUE) | United States | $0.060B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.044B | 0.00 |
ModivCare (MODV) | United States | $0.044B | 0.00 |
Basel Medical Group (BMGL) | Singapore | $0.042B | 0.00 |
OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.011B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.006B | 0.00 |
Aclarion (ACON) | United States | $0.004B | 0.00 |
ISpecimen (ISPC) | United States | $0.003B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
INVO Fertility (IVF) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.000B | 0.00 |